[Corneal collagen cross-linking to treat infectious keratitis].

[Corneal collagen cross-linking to treat infectious keratitis].
J Fr Ophtalmol. 2018 Jun 11;:
Authors: Atia R, Jouve L, Knoeri J, Georgeon C, Laroche L, Borderie V, Bouheraoua N
Abstract
Infectious keratitis are a frequent cause of ocular morbidity. Today, new treatments are necessary to combat the emergence of antibiotic resistant germs. Corneal collagen cross-linking has been suggested to treat corneal infectious (PACK-CXL). Its action would be both antimicrobial and protective for the cornea, increasing its biochemical resistence to proteolytic enzymes. In vivo, PACK-CXL might demonstrate good efficacy against bacterial keratitis, contrary to herpetic keratitis for which it is contraindicated. For fungal or amoebic keratitis, results are uncertain regarding its safety and efficacy. The purpose of this paper is to clarify the use of corneal collagen cross-linking to treat infectious keratitis.
PMID: 29903589 [PubMed - as supplied by publisher]

Source: Journal Francais d Ophtalmologie - June 16, 2018 Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research